Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
Paushak Limited, part of the Alembic Group, is India's largest manufacturer of phosgene-based specialty chemicals, with a strong focus on isocyanates and chloroformates among others.
The company operates out of a 'Responsible Care' certified plant in Gujarat with a capacity of 14,400 MT/year. It is notable for achieving high benchmarks in process safety and operational efficiencies.
Paushak engages in toll manufacturing and offers diverse chemical products used across pharmaceuticals, pesticides, dyes, and plastics, highlighting its versatile applications.
It maintains a substantial R&D footprint, supporting process development, with a dedicated in-house laboratory complementing its production capabilities.
Despite its niche focus in specialty chemicals, Paushak benefits from its association with Alembic Group, leveraging corporate support in various operational areas.
Chemicals & Petrochemicals
Specialty Chemicals
1,213 Cr
Moderate Risk
33.9
42.0
3.6
2.5
991.20
343.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Paushak Ltd (PAUSHAKLTD) is currently trading at 504.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Paushak Limited, part of the Alembic Group, is India's largest manufacturer of phosgene-based specialty chemicals, with a strong focus on isocyanates and chloroformates among others. The company operates out of a 'Responsible Care' certified plant in Gujarat with a capacity of 14,400 MT/year. It is notable for achieving high benchmarks in process safety and operational efficiencies. Paushak engages in toll manufacturing and offers diverse chemical products used across pharmaceuticals, pesticides, dyes, and plastics, highlighting its versatile applications. It maintains a substantial R&D footprint, supporting process development, with a dedicated in-house laboratory complementing its production capabilities. Despite its niche focus in specialty chemicals, Paushak benefits from its association with Alembic Group, leveraging corporate support in various operational areas.
Over the past 52 weeks, Paushak Ltd has traded between a low of ₹343.00 and a high of ₹991.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Paushak Ltd has a market capitalization of approximately 1,212.87. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Paushak Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.93 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,212.87 Cr, Paushak Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Paushak Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Paushak Ltd is 33.93. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
6
Neutral
3
Bullish
5
Bearish
15
Neutral
3
Bullish
28
Bearish
9
Neutral
0
Bullish
23
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
512.85 | 1,408 Cr | 268.51 | 32.50 | 0.00 | 8.95 | 9.77 | 3.68 | ||
203.30 | 1,230 Cr | 25.80 | 3.01 | 0.00 | 10.34 | 13.89 | 8.29 | ||
501.00 | 1,213 Cr | 33.93 | 2.53 | 0.51 | 9.47 | 10.40 | 5.87 | ||
883.00 | 1,195 Cr | 14.65 | 0.66 | 1.45 | 4.07 | 5.39 | 3.36 | ||
889.20 | 1,069 Cr | 15.60 | 4.53 | 1.01 | 29.00 | 38.69 | 18.24 | ||
274.55 | 1,057 Cr | 1247.95 | 1.60 | 0.16 | 1.48 | 4.86 | 0.06 | ||
152.00 | 925 Cr | 13.35 | 2.03 | 0.00 | 9.22 | 12.01 | 4.49 | ||
| Median: 7 Co. | — | 501.00 | 1,195 Cr | 25.80 | 2.53 | 0.16 | 9.22 | 10.40 | 4.49 |
Newspaper advertisement
Paushak Ltd published newspaper ads (17 Apr 2026) notifying shareholders of the IEPFA/MCA 'Second 100‑Day Saksham Niveshak' campaign (1 Apr–9 Jul 2026), urging KYC/bank mandate updates and ISR form submission to RTA to claim unclaimed/unpaid dividends and avoid transfer to IEPFA.
Director Appointment
Shareholders approved a special resolution appointing Mr. Jain Parkash (DIN: 10922687) as Whole-time Director effective April 17, 2026, with 1,67,68,343 votes (99.96%) in favour and 6,404 against via postal ballot.
